| Term 
 | Definition 
 
        | Cardiovascular (overall safety green) (G)Heart Failure: 50-200 mg/day. Maybe contradictory. Studies have shown benefit but others also have not found it benefit.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cardiovascular (likely safe) Possibly for BP and atherosclerosis
 ↑ INR in warfarin patients (case reports;  ↓ effectiveness of OCs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cardiovascular (overall safety green) (G)Hypertriglyceridemia: Reduction in TG levels. Cholesterol does not change and HDL increase a little. 1-6 g/day. Sidefects such as belching or halitosis.ardiovascular |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cardiovascular (overall safety black) Blood glucose monitoring
 Antiplatelet meds or herbs: possible additive effects
 (G)Leg Edema due to chronic venous insufficiency: Reduction of symptoms and leg volume. Safe and effacacious. 150 mg/day.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cardiovascular (overall safety green) (G) Intermittent Claudication (PAD): Improved symptoms and function. Safe though more research needed for efficacy. 10 mg BID
 (B)Hyperlipidemia/hypercholesterolemia: Efficacy only came from trials from one group others cant replicate efficacy. But since its safe its okay.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cardiovascular (OS - Green) Additive activity with used with statins
 (G) Hypercholesterolemia: Lowers cholesterol levels (LDL and TG). HDL also increased in one study. 1.2-2.4 g/daily
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cardiovascular (OS - Green) (G) Hyperlipidemia: Reduction of total cholesterol. Dose 40-50g/daily
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cardiovascular (OS - Green) (G) Hypercholesterolemia: Lowers cholesterol. 2-10g/day
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cardiovascular (OS - Black) (G) Heart Failure: Improve symptoms and execrcise tolerance. May interact with common HF meds like digoxin (so tell DR. 160-1800 mg/daily
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cardiovascular (OS - Green) (G) Hyperlipidemia: Increase HDL and decrease TG, LDL not defined. 200-600 mcg/day
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cardiovascular (OS- Green) (G) CHF: Improved function (exercise tolerance). Should be under supervision/monitored
 (B) Hypertension: Benefits seen whena dded to enalapril/HCTZ therapy. More research needed. Monitor BP carefully.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CENTRAL NERVOUS SYSTEM seasonal allergic rhinitis
 Asteracea (aster, daisy  or sunflower family) allergy
 Substrate of CYP34A; avoid with know inducers (i.e. carbamazepine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CENTRAL NERVOUS SYSTEM Migraine prophylaxis and treatment
 Asteracea (aster, daisy  or sunflower family) allergy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CENTRAL NERVOUS SYSTEM Alzheimer's disease
 |  | 
        |  | 
        
        | Term 
 
        | Ginko/Maidenhair tree (CV/CNS) |  | Definition 
 
        | CENTRAL NERVOUS SYSTEM Antiplatelets: possible additive / ↑ effect, Single case report of coma in patient taking low dose trazodone
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CENTRAL NERVOUS SYSTEM Anxiety disorders
 Levadopa: ↓ efficacy; concerns of hepatotoxicity contraindicates use with other meds and supplements that damage liver
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CENTRAL NERVOUS SYSTEM Sleep disorders in blind
 Nifedipine: ↓ absorption and delivery; Fluvoxamine, MAOIs, TCAs: ↑ melatonin effects
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CENTRAL NERVOUS SYSTEM CYP34A: ↓ levels and effects (e.g. alprazolam, amitriptyline, nifedipine, simvastatin, theophylline, warfarin); Antidepressants: ↑ risk of serotonin syndromes with nefazadone, sertraline, paroxetine, fluoxetine; ↓ cyclosporine levels case reports of graft rejections; OCs and HRTs: ↓ activity / effectiveness; ↓ serum levels of protease inhibitors and nonnucleoside reverse transcriptase inhibitors
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CENTRAL NERVOUS SYSTEM ↑ effects with alcohol or other CNS depressants (benzodiazepines)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CENTRAL NERVOUS SYSTEM SSRIs, tramadol, diabetic patients: ↑ risk of serotonergic side effects; Carbidoba: ↓ peripheral metabolism
 |  | 
        |  | 
        
        | Term 
 
        | SAMe (CNS and musculoskeletal) |  | Definition 
 
        | CENTRAL NERVOUS SYSTEM Depression
 |  | 
        |  | 
        
        | Term 
 
        | Probiotics (GI/immune modulator) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | GASTROINTESTINAL / LIVER Blood glucose monitoring (avoid use)
 Antiplatelets: possible additive /  ↑ effect at higher doses (> 4gm/d)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | GASTROINTESTINAL / LIVER Ragweed allergy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GASTROINTESTINAL / LIVER ↓ absorption of iron salts; premature dissolution of enteric-coated peppermint oil capsules by meds that increase gastric pH (H2 blockers, PPIs)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GASTROINTESTINAL / LIVER (generally safe) Constipation, Diarrhea, hemmorhoids, IBS, Weight loss and obseity
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GASTROINTESTINAL / LIVER (likely safe) Constipation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GASTROINTESTINAL / LIVER weight control
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | GASTROINTESTINAL / LIVER Diarrhea
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ENDOCRINE SYSTEM (might be safe for most) Blood glucose monitoring
 Type 2 diabetes, diabetic neuropathy
 ↑ bioavailability of valproate
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ENDOCRINE SYSTEM (OS - Green) (G) Postprandial Glucose Reduction:Dose 1-3g with meals.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Dehydroepiandrosterone (DHEA) |  | Definition 
 
        | ENDOCRINE SYSTEM (OS - Red) ↑ serum triazolam
 (G) Erectile Dysfunction: ED due to HTN or unknown etiology (not including neurological ED)
 (B) Sexual Arousal in women:no benefit in young premenopausal women. Self reported in postmenopausal woman benefits.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ENDOCRINE SYSTEM (OS - Black) Avoid using in Immune issue patients (AIDs , RA, Lupus)
 (B)Hypoglycemia, Hypocholesterolemia: significant glucose lowering agent but small (though statisticall significant) decrease in lipid. 1gm daily
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ENDOCRINE SYSTEM (no info about safety) Diabetes mellitus
 Menstrual pain, menorrhagia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ENDOCRINE SYSTEM (OS - Black) (G) Diabetes: significant decrease in fasting blood sugar and HgA1c. (counselled and monitor). 400 mg daily
 |  | 
        |  | 
        
        | Term 
 
        | Evening Primrose Oil (skin/endocrine) |  | Definition 
 
        | ENDOCRINE SYSTEM (OS - Green) (G) Diabetic Neuropathy: reduction of neuropathy symptoms, some with reversal of symptoms. 4gm daily
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Echinacea or Purple Cornflower |  | Definition 
 
        | IMMUNE MODULATORS Avoid using in Immune issue patients (AIDs , RA, Lupus)
 Asteracea (aster, daisy  or sunflower family) allergy
 |  | 
        |  | 
        
        | Term 
 
        | Probiotics (GI/Immune modulator) |  | Definition 
 
        | IMMUNE MODULATORS Separate dosing of antibiotics or antifungals by 2 or more hours
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PHYSICAL AND MENTAL PERFORMANCE ENHANCERS (OS - Green)
 (G) Enhance Athletic Performance: Improvement in performance related to high-intensity, repetitive tasks. Seem to occur only in trianed athletes. 15-20g/day then 2-10g day
 (B)Strength performance in older adults: 5-15g/day
 (B) Hemidialysis-induced leg cramps: reduced leg cramps
 |  | 
        |  | 
        
        | Term 
 
        | Eleuthero (siberian ginseng) |  | Definition 
 
        | PHYSICAL AND MENTAL PERFORMANCE ENHANCERS (OS - Black)
 Asteracea (aster, daisy  or sunflower family) allergy
 Possible false ↑ in serum digoxin (assay dependent); Caffeine ↑ CNS stimulation
 (B) Stress Adaptation: improvement in CV response to stress.
 (B) Chronic fatigue: No significant improvement over placebo, but statistically significant from baseline with moderate fatigue.
 (R) Athletic Performance: No evidence
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PHYSICAL AND MENTAL PERFORMANCE ENHANCERS (OS - Green)
 Oral hypoglycemics: possible lowered BG levels; Must self-monitor BG
 (G) ED: 900mg or 1800 (extract(
 (B) Cognition:Improvement in specific areas of cognition (abstract thinking). Long term safety evidence lacking.
 (B)Athletic performance: Slight benefit in psychomotor activities, such as reaction time or concentration
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PHYSICAL AND MENTAL PERFORMANCE ENHANCERS (OS - Green)
 Decongestants: ↑ stimulant effects
 (R) weight Loss) no evidence supporting
 |  | 
        |  | 
        
        | Term 
 
        | Pygeum (African Plum Tree) |  | Definition 
 
        | KIDNEY, URINARY TRACT & PROSTATE (OS - Green)
 (G): BPH: Decrease in symptoms and improvement in urodynamics. No effect in prostate volume. 100-200 mg/day
 Sometimes found in saw palmetto or pumpkin.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | KIDNEY, URINARY TRACT & PROSTATE (OS - Green)
 UTI prevention: Several studies show effectiveness in prevention. has drug interactions.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | KIDNEY, URINARY TRACT & PROSTATE (OS - Green)
 (G)BPH: Decrease symptoms and improves flowmetry. No effect on volume. Does not support a recommendation for treatment of mild BPH. Can mask symptoms of prostate cancer
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | KIDNEY, URINARY TRACT & PROSTATE ↑ serum triazolam
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | KIDNEY, URINARY TRACT & PROSTATE (OS - Green)
 (G) - Treatment of Prostate Cancer: May improve prostate cancer-related markers such as PSA. Better Treatment and survival when combined with orchidectomy.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | KIDNEY, URINARY TRACT & PROSTATE (OS - Green)
 (G) Prostate Cancer prevention:
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MUSCULOSKELETAL (OS - Green) Shellfish allergy
 Blood glucose monitoring
 (G) Osteoarthritis: most highly researched dietary supplement. First line agent for treatment of osteoarthritis. (knee) others might not be as reliable. May take several months. May continue NSAID or APAP.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MUSCULOSKELETAL (OS - Green) (G) Osteoarthritis: Benefit to reduce pain and increase function. Fewer new joint erosions. combined with glucosamine. no evidence show that combo is better, also more expensive.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MUSCULOSKELETAL (OS - Green) (G) Low Back Pain: recommendation of use for low back pain (reduces NSAID use)
 (G) Osteoarthritis: Small studies found improvement in OA. Comparable to diacerhein. More research needed for longterm effect and efficacy.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MUSCULOSKELETAL (OS - Green) (G)Osteoarthritis: gum has been used in ayurvedic medicinal therapies for centuries for inflam disease. can be cautiously recommended.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MUSCULOSKELETAL (OS - Black) (G) Lower Back Pain: Significant benefit in reduction of backpain symptoms. time to imrpovement usualy longer and cost was less.
 (B) Osteoarthritis: Can not be recommended for OA ATM.
 Number of allergic and AE compare to placebo/conventional treatments. Same risk of gastric ulcer.
 |  | 
        |  | 
        
        | Term 
 
        | Methyl-sulfonyl-methane (MSM) |  | Definition 
 
        | MUSCULOSKELETAL (OS - Green) (B) Osteoarthritis:  Benefits were noted and side effects minimal. More research needed to determine extent of efficacy and long term safety. cant be recommended.
 |  | 
        |  | 
        
        | Term 
 
        | S-adenosyl-L-methionine (SAMe) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | SKIN AND MUCOUS MEMBRANES (topical OS - Green, Oral - Red)
 (G) Psoriasis: Evidence limited but may help reduce psoriatic lesions
 (B) Wound Healing: Commonly used in minor wounds and burns but no clinical evidence supports this use.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SKIN AND MUCOUS MEMBRANES Ragweed allergy
 Atopic eczema
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SKIN AND MUCOUS MEMBRANES (OS - Green) (G) Herpes Labialis (cold Sores): May be effective for shortening duration. No sufficient info to make general recommendation.
 (B) Agitation Associated with dementia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SKIN AND MUCOUS MEMBRANES (OS - Green) (G) Acne: Affective for treating acne but less effective than benzoyl peroxide, but less incidence of skin irritation was reported. May be an option if cant tolerate Benzoyl P.
 (G) Dandruff: for who cannot tolerate standard treatment.
 (G) Athletes foot: not as effective as clotrimazole creams.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SKIN AND MUCOUS MEMBRANES (OS - Black) (B) Atopic Dermatitis: no evidence but one trial had an effect.
 (B) periodontitis: Not enough evidence for recommendation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SKIN AND MUCOUS MEMBRANES |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SKIN AND MUCOUS MEMBRANES (OS - Black) (G) Oral leukoplakia: Lesions on tongue. Shouldnt be used as monotherapy.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | WOMEN’S HEALTH Premenstrual syndrome
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | EYES Age-related macular degeneration
 |  | 
        |  | 
        
        | Term 
 
        | Possible interaction with warfarin and or antiplatelets |  | Definition 
 
        | Chondroitin, Coenzyme Q10, Cranberry, Devils claw, evening primrose, fenugreek, feverfew garlic, ginko, ginseng, Green tea, fish oil, kava, phytoestrogens, policosanol, saw palmetto, st johns wart. |  | 
        |  |